231 related articles for article (PubMed ID: 30451843)
1. Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy.
Gayi E; Neff LA; Massana Muñoz X; Ismail HM; Sierra M; Mercier T; Décosterd LA; Laporte J; Cowling BS; Dorchies OM; Scapozza L
Nat Commun; 2018 Nov; 9(1):4848. PubMed ID: 30451843
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen therapy in a murine model of myotubular myopathy.
Maani N; Sabha N; Rezai K; Ramani A; Groom L; Eltayeb N; Mavandadnejad F; Pang A; Russo G; Brudno M; Haucke V; Dirksen RT; Dowling JJ
Nat Commun; 2018 Nov; 9(1):4849. PubMed ID: 30451841
[TBL] [Abstract][Full Text] [Related]
3. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
Cowling BS; Chevremont T; Prokic I; Kretz C; Ferry A; Coirault C; Koutsopoulos O; Laugel V; Romero NB; Laporte J
J Clin Invest; 2014 Mar; 124(3):1350-63. PubMed ID: 24569376
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase inhibition restores Ca2+ release defects and prolongs survival in myotubularin-deficient mice.
Kutchukian C; Lo Scrudato M; Tourneur Y; Poulard K; Vignaud A; Berthier C; Allard B; Lawlor MW; Buj-Bello A; Jacquemond V
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14432-14437. PubMed ID: 27911767
[TBL] [Abstract][Full Text] [Related]
5. Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.
Tasfaout H; Lionello VM; Kretz C; Koebel P; Messaddeq N; Bitz D; Laporte J; Cowling BS
Mol Ther; 2018 Apr; 26(4):1082-1092. PubMed ID: 29506908
[TBL] [Abstract][Full Text] [Related]
6. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.
Ross JA; Tasfaout H; Levy Y; Morgan J; Cowling BS; Laporte J; Zanoteli E; Romero NB; Lowe DA; Jungbluth H; Lawlor MW; Mack DL; Ochala J
Acta Neuropathol Commun; 2020 Oct; 8(1):167. PubMed ID: 33076971
[TBL] [Abstract][Full Text] [Related]
7. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.
Bachmann C; Jungbluth H; Muntoni F; Manzur AY; Zorzato F; Treves S
Hum Mol Genet; 2017 Jan; 26(2):320-332. PubMed ID: 28007904
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
Tasfaout H; Buono S; Guo S; Kretz C; Messaddeq N; Booten S; Greenlee S; Monia BP; Cowling BS; Laporte J
Nat Commun; 2017 Jun; 8():15661. PubMed ID: 28589938
[TBL] [Abstract][Full Text] [Related]
9. Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.
Danièle N; Moal C; Julien L; Marinello M; Jamet T; Martin S; Vignaud A; Lawlor MW; Buj-Bello A
J Neuropathol Exp Neurol; 2018 Apr; 77(4):282-295. PubMed ID: 29408998
[TBL] [Abstract][Full Text] [Related]
10. AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.
Buj-Bello A; Fougerousse F; Schwab Y; Messaddeq N; Spehner D; Pierson CR; Durand M; Kretz C; Danos O; Douar AM; Beggs AH; Schultz P; Montus M; Denèfle P; Mandel JL
Hum Mol Genet; 2008 Jul; 17(14):2132-43. PubMed ID: 18434328
[TBL] [Abstract][Full Text] [Related]
11. Normal innervation and differentiation of X-linked myotubular myopathy muscle cells in a nerve-muscle coculture system.
Dorchies OM; Laporte J; Wagner S; Hindelang C; Warter JM; Mandel JL; Poindron P
Neuromuscul Disord; 2001 Nov; 11(8):736-46. PubMed ID: 11595516
[TBL] [Abstract][Full Text] [Related]
12. Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice.
Amoasii L; Bertazzi DL; Tronchère H; Hnia K; Chicanne G; Rinaldi B; Cowling BS; Ferry A; Klaholz B; Payrastre B; Laporte J; Friant S
PLoS Genet; 2012; 8(10):e1002965. PubMed ID: 23071445
[TBL] [Abstract][Full Text] [Related]
13. Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy.
Lawlor MW; Armstrong D; Viola MG; Widrick JJ; Meng H; Grange RW; Childers MK; Hsu CP; O'Callaghan M; Pierson CR; Buj-Bello A; Beggs AH
Hum Mol Genet; 2013 Apr; 22(8):1525-38. PubMed ID: 23307925
[TBL] [Abstract][Full Text] [Related]
14. "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.
Bevilacqua JA; Bitoun M; Biancalana V; Oldfors A; Stoltenburg G; Claeys KG; Lacène E; Brochier G; Manéré L; Laforêt P; Eymard B; Guicheney P; Fardeau M; Romero NB
Acta Neuropathol; 2009 Mar; 117(3):283-91. PubMed ID: 19084976
[TBL] [Abstract][Full Text] [Related]
15. X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition.
Volpatti JR; Ghahramani-Seno MM; Mansat M; Sabha N; Sarikaya E; Goodman SJ; Chater-Diehl E; Celik A; Pannia E; Froment C; Combes-Soia L; Maani N; Yuki KE; Chicanne G; Uusküla-Reimand L; Monis S; Alvi SA; Genetti CA; Payrastre B; Beggs AH; Bonnemann CG; Muntoni F; Wilson MD; Weksberg R; Viaud J; Dowling JJ
Acta Neuropathol; 2022 Sep; 144(3):537-563. PubMed ID: 35844027
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies.
Djeddi S; Reiss D; Menuet A; Freismuth S; de Carvalho Neves J; Djerroud S; Massana-Muñoz X; Sosson AS; Kretz C; Raffelsberger W; Keime C; Dorchies OM; Thompson J; Laporte J
Mol Ther; 2021 Aug; 29(8):2514-2534. PubMed ID: 33940157
[TBL] [Abstract][Full Text] [Related]
17. Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways.
Al-Qusairi L; Prokic I; Amoasii L; Kretz C; Messaddeq N; Mandel JL; Laporte J
FASEB J; 2013 Aug; 27(8):3384-94. PubMed ID: 23695157
[TBL] [Abstract][Full Text] [Related]
18. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.
Pierson CR; Dulin-Smith AN; Durban AN; Marshall ML; Marshall JT; Snyder AD; Naiyer N; Gladman JT; Chandler DS; Lawlor MW; Buj-Bello A; Dowling JJ; Beggs AH
Hum Mol Genet; 2012 Feb; 21(4):811-25. PubMed ID: 22068590
[TBL] [Abstract][Full Text] [Related]
19. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.
Biancalana V; Scheidecker S; Miguet M; Laquerrière A; Romero NB; Stojkovic T; Abath Neto O; Mercier S; Voermans N; Tanner L; Rogers C; Ollagnon-Roman E; Roper H; Boutte C; Ben-Shachar S; Lornage X; Vasli N; Schaefer E; Laforet P; Pouget J; Moerman A; Pasquier L; Marcorelle P; Magot A; Küsters B; Streichenberger N; Tranchant C; Dondaine N; Schneider R; Gasnier C; Calmels N; Kremer V; Nguyen K; Perrier J; Kamsteeg EJ; Carlier P; Carlier RY; Thompson J; Boland A; Deleuze JF; Fardeau M; Zanoteli E; Eymard B; Laporte J
Acta Neuropathol; 2017 Dec; 134(6):889-904. PubMed ID: 28685322
[TBL] [Abstract][Full Text] [Related]
20. The intragenic microRNA
Chen X; Gao YQ; Zheng YY; Wang W; Wang P; Liang J; Zhao W; Tao T; Sun J; Wei L; Li Y; Zhou Y; Gan Z; Zhang X; Chen HQ; Zhu MS
J Biol Chem; 2020 Jun; 295(26):8656-8667. PubMed ID: 32354746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
